Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pseudouridine 5'-phosphatase pseudogene 3 (PUDPP3) is a human pseudogene, previously referred to by alternative names such as HDHD1DP or HDHD1P3, and is a member of the haloacid dehalogenase-like hydrolase domain containing family. This gene is annotated as a pseudogene, meaning it does not encode a functional protein product and is not considered a therapeutic target. There are no known biological functions, associated disease roles, interacting drugs, or biomarker utility for PUDPP3. Notes: - This entry refers to a pseudogene, not a functional protein, enzyme, receptor, or drug target. - There is no evidence supporting its use as a therapeutic target or biomarker, nor associated safety concerns, mechanisms of action, or disease relevance based on available curated databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudouridine 5'-phosphatase pseudogene 3 (PUDPP3).